These results indicates that DLX6-AS1 accelerates cell proliferation, migration, and invasion of BC cells through targeting miR-195-5p and mediating VEGFA/Ras/Raf/MEK/ERK signaling pathway. Here, MAP2K7 is linked to breast cancer.